Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells

Guan-Liang Lin(National University of Tainan), Yu‐Li Lo(Institute of Pharmacology)
PLoS ONE
October 2, 2017
10.1371/journal.pone.0185625
Cited by 47

Related Papers

Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
|Journal of Nanobiotechnology|2019|60
Gene-editing by CRISPR–Cas9 in combination with anthracycline therapy <i>via</i> tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression
|Nanoscale Horizons|2021|57
Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal Carcinoma
|PLoS ONE|2013|43
Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2&amp;ndash;3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells
|International Journal of Nanomedicine|2016|40
Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics
|Pharmaceutics|2020|19